Follow @brianferoldi
Recent articles
New Relic Is Investing in Its Future
The cloud-based software company is hiring like crazy in an effort to drive its next phase of growth.
NIC Pulls Its Profit Guidance After a Tough Quarter
Unexpected costs are hitting the government software provider's bottom line hard.
Why MannKind Is Up Big Today
Shares rise after the company receives some praise from a pair of Wall Street analysts.
Why Endo International Shares Are Under Pressure Today
Traders knock down the stock in response to an analyst downgrade.
ShockWave Medical's Revenue Soars in Its Public Debut
The medical device maker's first earnings report as a public company featured explosive revenue growth and upbeat full-year guidance.
2 Winners and 2 Losers in the Med Tech Market This Quarter
Medical devices can be ultra reliable, lucrative business, but there are plenty of ways for companies to blow it, too.
Why Guardant Health Is Soaring Today
Traders bid up the stock in response to another strong earnings report.
SailPoint Technologies Holdings Cuts Full-Year Guidance
The cybersecurity company reported good first-quarter results but stated that its business momentum is slowing down.
Infinera Guides for a Rough Quarter Ahead
The company is winning its fair share of new business, but some big projects are taking a long time to come to fruition.
Here's Why SailPoint Technologies Holdings Is Tanking Today
First-quarter results looked good, but the company's guidance left investors wanting more.
Why Infinera Stock Is Getting Slammed Today
Shares fall hard after the company reported mixed first-quarter results and issued weak guidance.
AppFolio's Revenue Growth Accelerates
The software-as-a-service business is sacrificing near-term profit growth in an effort to maximize revenue growth.
Why Inogen Shares Are Plunging Today
The stock sinks after the medical device marker slashes its full-year guidance.
Why Corindus Vascular Robotics Is Soaring Today
Shares jump even though its first-quarter results fell short of Wall Street's estimates. What can explain the optimism?
Why Intersect ENT Is Getting Mauled Today
Shares fall hard after the company reports rough first-quarter results and announces a leadership transition.
5 Key Takeaways From NovoCure's Big First Quarter
Management talks about international expansion, potential FDA approval, and Medicare reimbursement.
ResMed's Revenue Growth Accelerates
The medical-device maker continues to roll out new products and grab market share.
Appian Meets Its Targets but Tweaks Its Guidance
Management's decision to play the long game is weighing on near-term revenue and profit growth.
Why Emergent BioSolutions Stock Is Tanking Today
Shares drop after the company reports first-quarter results that missed the mark.
Here's Why ViewRay Is on the Upswing Today
First-quarter results missed the mark, but traders are feeling upbeat because this company's backlog continues to grow.